<DOC>
	<DOCNO>NCT00017446</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness CP4071 treat patient locally advance metastatic soft tissue sarcoma .</brief_summary>
	<brief_title>CP4071 Treating Patients With Locally Advanced Metastatic Soft Tissue Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy , term response rate , CP4071 patient previously treat , locally advanced metastatic soft tissue sarcoma . - Determine clinical toxic effect drug patient . OUTLINE : Patients receive oral CP4071 daily . Treatment continue absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 25 patient accrue study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Digitoxin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm soft tissue sarcoma Metastatic locally advance Failed least 1 prior therapy Measurable disease outside prior irradiation field No CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : SWOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Bilirubin great 2 time upper limit normal ( ULN ) Renal : Creatinine le 1.5 time ULN Calcium less ULN Potassium normal Other : No malignancy within past 5 year except stage I II cancer complete remission , carcinoma situ cervix , basal cell squamous cell skin cancer Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Prior biologic response modifier therapy allow Chemotherapy : No 3 prior chemotherapy regimen advance , recurrent , metastatic disease No concurrent chemotherapy Endocrine therapy : No concurrent hormonal therapy malignancy Radiotherapy : See Disease Characteristics At least 3 week since prior radiotherapy recover No concurrent radiotherapy Surgery : At least 4 week since prior surgery recover Other : No concurrent cardiac glycoside</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2002</verification_date>
	<keyword>stage III adult soft tissue sarcoma</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
</DOC>